Novo CEO pressed by Senate to chop prices of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen told lawmakers the company would take into account new talks with insurers with regard to the record costs of Wegovy and copyright whenever they pledge to help keep the medicines on their own formularies. https://dallasyulgx.azzablog.com/30762900/everything-about-healthcare-news